1Heart Protection Study Collaborative Group, Jonathan Ember- son, Derrick Bennett, et al. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20, 536 patients in the Heart PrOtection StudyE J]. Lancet,2011, 377(9764) :469-476.
2Yagi S, Aihara K, Ikeda Y, et al. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II-induced cardiovascular remodeling and renal insufficiency [ J ]. Circ Res,2008,102 ( 1 ) :68-76.
